Return to Results

Barostim HOPE4HF Study

new search

Trial Conditions
  • Heart Failure
What is the purpose of this trial?

The purpose of this research study is to show whether the Neo system is safe and works in people with heart failure.

Date & Status


Who can Participate?


21 and older



Inclusion Criteria:

- Age 21 years or above.

- On optimal, guideline-directed (per the American Heart Association/American
College of Cardiology guidelines), stable, heart-failure medications and dose for at
least 4 weeks prior to screening.

Exclusion Criteria:

- Known or suspected baroreflex failure or autonomic neuropathy.

- Myocardial infarction, unstable angina, syncope, cerebral vascular accident, sudden
cardiac death (SCD), or received defibrillation therapy within 3 months.

- Heart failure secondary to a reversible cause or treatable condition.

Gender: Both
Trial Interventions
  • Barostim Neo system
Other Information

Sponsor: CVRx, Inc.
Phase: N/A
Trial ID: NCT01720160
Volunteers:  Not Accepting Healthy Volunteers

new search

Connect with Steward

Visit Our Twitter Feed Visit Our Facebook Page Email This Page Print This Page

Subscribe to our patient e-newsletter

Copyright © 2015 Steward Health Care
Connect Healthcare Panacea CMS Solutions